CA
NZ
UK
AU
IND
US
A modest single-session slide has put Kardigan, Inc (NASDAQ:KARD) back into view, with the cardiovascular-focused biopharmaceutical company's shares closing down 0.91% at $18.52 at last closing. Kardigan is one of the year's higher-profile healthcare debutants, pairing a late-stage cardiac pipeline with a data-driven discovery …
Green Hygienics, Inc (OTC:GRHY) is a dormant sub-penny name whose context matters far more than any single day's quote. Once positioned around bamboo-based hygiene products and, earlier still, hemp ventures, the company has not filed with regulators in years, and no independently verifiable trading …
Few 2026 biotech debuts arrived with as much momentum as Braveheart Bio, Inc (NASDAQ:BRVE). The cardiovascular-focused drug developer priced one of the summer's larger biotech IPOs, drew a wave of bullishWall Streetcoverage, and moved straight into late-stage testing of its lead heart medicine. Shares …
BioXcel Therapeutics, Inc. (OTC:BTAIQ) is a shadow of the AI-driven biotech that once traded well into the double digits on the Nasdaq. Now quoted for pennies on the over-the-counter market, the stock can still post eye-catching percentage swings on very little volume, and the …
Few tickers illustrate the fate of the pandemic-era cannabidiol boom as starkly as Hempfusion Wellness Inc. (OTC:CBDHF). Once a well-distributed U.S. CBD and wellnessBrandwith shelves in thousands of retail stores, the company now trades at a fraction of a cent on the over-the-counter market, …
Conexeu Sciences Inc has quietly become one of the more distinctive biotechnology newcomers on theNasdaqthis year, a preclinical regenerative-medicine story that only reached public markets in 2026. Trading under the ticker CNXU, shares closed up 4.94% at $4.46 at last closing, putting technical levels …
A quietTrading sessioncan mask a busy year. Hemab Therapeutics Holdings, whose shares closed down 1.20% at $39.40 at last closing, spent the spring and summer of 2026 building a clinical dossier around rare and serious bleeding disorders while its stock more than doubled from …
There is penny-stock territory, and then there is what Bellrock Brands (OTC:DXBRF) has become. The cannabis products company changes hands at a fraction of a cent, a price that leaves its entire public equity valued at little more than pocket change. No independently verifiable …
Eikon Therapeutics, Inc. has long been one of biotechnology's better-known platform stories, and its move ontoNasdaqunder the ticker EIKN has given public investors a way to follow it. Shares closed down 2.93% at $8.94 at last closing even as the company signals a step …
Few tickers illustrate the mechanics of the sub-penny market quite like Energy Resource Abundance, Inc. (OTC:ERAO). Trading at a fraction of a cent, shares closed up 44% at last closing, an eye-catching figure that sounds dramatic, yet at these price levels a move of …
Please wait processing your request...